According to audited financial statements, JMI Syringes incurred a loss of Tk6.02 crore in the 2026 fiscal year. This marks a significant downturn from the previous fiscal year, when the company recorded a net profit of Tk4.49 crore in FY25. Despite the financial loss, the company's board has recommended a 10% cash dividend for shareholders.
Economy
JMI Syringes reports Tk6 crore loss in FY26, declares 10% cash dividend
Despite posting a loss of over Tk6 crore in the latest fiscal year, JMI Syringes has recommended a 10% cash dividend for its shareholders.
Source: The Business Standard